If you wonder who is leading the neurotech revolution, you should definitely consider the organizations who are attending next week's Neurotech Industry Conference among them. The event is nearly sold out, so if you haven't signed up yet, I recommend you don't wait any longer.

Hear from investors, researchers and executives about next generation treatments for Alzheimer's, addiction, anxiety, depression, epilepsy, hearing loss, insomnia, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, stroke and other brain-related illnesses.

NETWORK WITH REPRESENTATIVES FROM THE FOLLOWING FIRMS:
Aberdare Ventures, Accelerate Brain Cancer Cure, Accera, Inc., Accuitive Medical Ventures, Acumen Pharmaceuticals, Advanced Neuromodulation Systems, Afferent Corporation, Alatheia, Ltd., Allen Brain Institute, Amarin Corporation, Argolyn Biosciences, Athenagen, Avigen, Bay City Capital, Biotechnology Value Fund, Brain Resource Company, BrainCells Inc., BrainVital Corporation, Bristol-Myers Squibb, Center for Cognitive Liberty, Ceregene, Chevron Molecular Diamond Technologies, CNS Response, CoAxia, Confirma, Cyberkinetics Neurotechnology Systems, Cytodome, Inc., De Novo Ventures, DNA Bridges, Ernest Gallo Clinic and Research Center, Electrical Geodesics, GE Global Research Center, GE Healthcare, GlaxoSmithKline, Harvard Medical School, HealthPartners Research Foundation, Innovative Neurotechnologies, Intellectual Licensing Group, Jazz Pharmaceuticals, Lawrence Berkeley National Lab, Leptos Biomedical, Life Science Angels, Lighthouse Capital Partners, Limerick NeuroScience, Liverpool University, McGovern Institute for Brain Research, MDS Capital, Medtronic, MIT Technology Review, Nascent Enterprises, Neuro HiTech Pharmaceuticals, NeuroInvestment, Neurologix, Neuronetics, NeuroNova, Neuroscience Institute at Stanford, Neurotech Reports, NeuroVentures Capital, New York Times, NIH/ NINDS, Nixon Peabody, LLP, Novartis, NsGene, Pequot Ventures, Pfizer, Point Biomedical, Predix Pharmaceuticals, Preston Gates Ellis & Rouvelas Meeds LLP, Prospect Ventures, Purdue Research Foundation, Research Corporation Technology, Revere Data, Rinat Neuroscience, Saegis Pharmaceuticals, Sanderling, Science Futures, Sound Pharmaceuticals, Stanford University, Stem Cell Sciences, Stem Cells, Inc., Stryker, Takeda Research Investment, Targacept, Technology Partners, Tessera, Inc., The Foundry, University of California, San Francisco, Vanda Pharmaceuticals, VIASYS Healthcare, Wachovia Securities, Woodside Capital, Wyeth...

To register and for more information, please visit the NeuroInsights website at: www.neuroinsights.com or call (415) 229-3225.